Genitourinary Tuberculosis

  • James E. Gow

Abstract

Tuberculosis is a disease that has been known for many thousands of years, because the remains of ancient skeletons have shown the characteristic changes of tuberculosis. It is a disease that used to carry a high mortality, indeed, very little progress was made until the discovery of the antituberculous drugs, particularly streptomycin in 1943, isoniazid in 1952, and rifampicin in 1966.

Keywords

Tuberculosis Bacillus Streptomycin Prednisolone Digoxin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sutherland I: Recent studies in the epidemiology of tuberculosis based on the risk of being infected by the tubercle bacillus. Adv Tuberc Res 19:1, 1976.PubMedGoogle Scholar
  2. 2.
    Grosset J: The sterilising value of rifampicin and pyrazinamide in experimental short course chemotherapy. Tubercle 59:287, 1978.CrossRefGoogle Scholar
  3. 3.
    Mitchison DA: Treatment of tuberculosis. JR Coll Physic (London) 14:91, 1980.Google Scholar
  4. 4.
    British Thoracic Association: Short course therapy in pulmonary tuberculosis. Lancet 1:1182, 1980.Google Scholar
  5. 5.
    McAllister WAC, Thompson PJ, Al-Habet SM, Rogers HJ: Rifampicin reduces effectiveness and bio-availability of prednisolone. Br Med J 286:923, 1983.CrossRefGoogle Scholar
  6. 6.
    Osterhage HR, Fischer U, Barbensak K: Positive histological tuberculous findings despite stable sterility of the urine on culture. Eur Urol 6(2):116, 1980.PubMedGoogle Scholar
  7. 7.
    Gow JG, Barbosa S: Genito-urinary tuberculosis — a study of 1117 cases over a period of 34 years. Br J Urol 56:449, 1984.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1991

Authors and Affiliations

  • James E. Gow

There are no affiliations available

Personalised recommendations